READ: ARW ON RNA

71. What Playing RISK Can Teach Us About mRNA Manufacturing 7/11/2022

    On the surface, it may seem as though there is little in common between playing a board game and manufacturing mRNA therapeutics. But as I see it, strategizing, playing, and winning at RISK is highly analogous to the challenges mRNA therapeutics companies will face as they strive to achieve a well-controlled and understood commercial scale manufacturing process.